Statera Biopharma, Inc. — Form D

Statera Biopharma, Inc. of Fort Collins, CO, a company, filed a Form D exempt-offering notice with the SEC on 2014-07-03. The offering totals $3.5M, of which $3.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (56)

Showing 25 of 56 people.

NameRoleLocation
James R AntalDirectorBuffalo, NY
Julia R BrownDirectorBothell, WA
Andrei R GudkovDirectorBuffalo, NY
Daniel F HothDirectorBuffalo, NY
Yakov F KoganDirectorBuffalo, NY
Alexander R PolinskyDirectorBuffalo, NY
Andrei R GudkovExecutive OfficerBuffalo, NY
Yakov KoganDirectorSalt Lake City, UT
Yakov KoganExecutive OfficerSalt Lake City, UT
Richard S McGowanDirectorWESTMINSTER, MA
Daniel PerezDirectorSan Francisco, CA
Robert Kevin BuckheitExecutive OfficerFort Collins, CO
Blake Kevin HawleyDirectorFort Collins, CO
Satish Kevin ChandrenDirectorFort Collins, CO
Uday Kevin SaxenaDirectorFort Collins, CO
John Kevin KallassyDirectorFort Collins, CO
Michael Kevin HandleyDirectorFort Collins, CO
Michael Kevin HandleyExecutive OfficerFort Collins, CO
Michael Kevin HandleyPromoterFort Collins, CO
Christopher Kevin ZoshExecutive OfficerFort Collins, CO
Alexander S AndryushechkinDirectorBuffalo, NY
Andrei S Gudkov, Ph.D., D., Sci.Executive OfficerBuffalo, NY
Langdon S Miller, MDExecutive OfficerBuffalo, NY
Lea S VernyDirectorBuffalo, NY
Christopher ZoshExecutive OfficerBuffalo, NY

Other filings by this issuer (6)

FiledFormOfferingSold
2022-11-07D$765K$577K
2020-06-04D$1.6M$1.6M
2015-12-23D$1.1M$1.1M
2015-07-16D$25.0M$25.0M
2010-03-05D$5.0M$5.0M
2009-04-03D$3.7M$3.7M

More